Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations

被引:56
作者
Pearson, Josh T.
Hill, John J.
Swank, Jennifer
Isoherranen, Nina
Kunze, Kent L.
Atkins, William M.
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[3] Icos Corp, Bothell, WA 98021 USA
关键词
D O I
10.1021/bi0600042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heme-containing cytochrome P450s (CYPs) are a major enzymatic determinant of drug clearance and drug-drug interactions. The CYP3A4 isoform is inhibited by antifungal imidazoles or triazoles, which form low-spin heme iron complexes via formation of a nitrogen-ferric iron coordinate bond. However, CYP3A4 also slowly oxidizes the antifungal itraconazole (ITZ) at a site that is similar to 25 angstrom from the triazole nitrogens, suggesting that large antifungal azoles can adopt multiple orientations within the CYP3A4 active site. Here, we report a surface plasmon resonance (SPR) analysis with kinetic resolution of two binding modes of ITZ, and the related drug ketoconazole (KTZ). SPR reveals a very slow off-rate for one binding orientation. Multiphasic binding kinetics are observed, and one of the two binding components resolved by curve fitting exhibits "equilibrium overshoot". Preloading of CYP3A4 with the heme ligand imidazole abolishes this component of the antifungal azole binding trajectories, and it eliminates the conspicuously slow off-rate. The fractional populations of CYP3A4 complexes corresponding to different drug orientations can be manipulated by altering the duration of the pulse of drug exposure. UV-vis difference absorbance titrations yield low-spin spectra and K-D values that are consistent with the high-affinity complex resolved by SPR. These results demonstrate that ITZ and KTZ bind in multiple orientations, including a catalytically productive mode and a slowly dissociating inhibitory mode. Most importantly, they provide the first example of a SPR-based method for the kinetic characterization of binding of a drug to any human CYP, including mechanistic insight not available from other methods.
引用
收藏
页码:6341 / 6353
页数:13
相关论文
共 57 条
[31]  
Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644
[32]   THEORY FOR THE OBSERVED ISOTOPE EFFECTS FROM ENZYMATIC SYSTEMS THAT FORM MULTIPLE PRODUCTS VIA BRANCHED REACTION PATHWAYS - CYTOCHROME-P-450 [J].
KORZEKWA, KR ;
TRAGER, WF ;
GILLETTE, JR .
BIOCHEMISTRY, 1989, 28 (23) :9012-9018
[33]   Structural diversities of active site in clinical azole-bound forms between sterol 14α-demethylases ( CYP51s) from human and Mycobacterium tuberculosis [J].
Matsuura, K ;
Yoshioka, S ;
Tosha, T ;
Hori, H ;
Ishimori, K ;
Kitagawa, T ;
Morishima, I ;
Kagawa, N ;
Waterman, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) :9088-9096
[34]   Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-α-methadol in opioid-naive individuals [J].
Moody, DE ;
Walsh, SL ;
Rollins, DE ;
Neff, JA ;
Huang, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (02) :154-166
[35]  
Myszka DG, 2000, METHOD ENZYMOL, V323, P325
[36]   Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro [J].
Omar, G ;
Whiting, PH ;
Hawksworth, GM ;
Humphrey, MJ ;
Burke, MD .
THERAPEUTIC DRUG MONITORING, 1997, 19 (04) :436-445
[37]  
OMURA T, 1964, J BIOL CHEM, V239, P2379
[38]  
Ortiz de Montellano P. R., 2015, Cytochrome P450: structure, mechanism, and biochemistry, V4th
[39]   Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors [J].
Podust, LM ;
Poulos, TL ;
Waterman, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3068-3073
[40]   Advances in surface plasmon resonance biosensor analysis [J].
Rich, RL ;
Myszka, DG .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (01) :54-61